Literature DB >> 15273570

Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease.

Alberto Patriti, Enrico Facchiano, Annibale Donini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15273570      PMCID： PMC1356425          DOI： 10.1097/01.sla.0000134632.08789.df

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  18 in total

Review 1.  The glucagon-like peptides.

Authors:  T J Kieffer; J F Habener
Journal:  Endocr Rev       Date:  1999-12       Impact factor: 19.871

2.  Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.

Authors:  T Vilsbøll; T Krarup; C F Deacon; S Madsbad; J J Holst
Journal:  Diabetes       Date:  2001-03       Impact factor: 9.461

3.  Results of 281 consecutive total laparoscopic Roux-en-Y gastric bypasses to treat morbid obesity.

Authors:  Eric J DeMaria; Harvey J Sugerman; John M Kellum; Jill G Meador; Luke G Wolfe
Journal:  Ann Surg       Date:  2002-05       Impact factor: 12.969

4.  Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients.

Authors:  M B Toft-Nielsen; M B Damholt; S Madsbad; L M Hilsted; T E Hughes; B K Michelsen; J J Holst
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

5.  Glucagon-like peptide (GLP)-1 and leptin concentrations in obese patients with Type 2 diabetes mellitus.

Authors:  E Mannucci; A Ognibene; F Cremasco; G Bardini; A Mencucci; E Pierazzuoli; S Ciani; A Fanelli; G Messeri; C M Rotella
Journal:  Diabet Med       Date:  2000-10       Impact factor: 4.359

6.  Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease.

Authors:  Francesco Rubino; Jacques Marescaux
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

Review 7.  Gastric inhibitory polypeptide: the neglected incretin revisited.

Authors:  Juris J Meier; Michael A Nauck; Wolfgang E Schmidt; Baptist Gallwitz
Journal:  Regul Pept       Date:  2002-07-15

8.  Gut hormone changes after jejunoileal (JIB) or biliopancreatic (BPB) bypass surgery for morbid obesity.

Authors:  D L Sarson; N Scopinaro; S R Bloom
Journal:  Int J Obes       Date:  1981

9.  Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus.

Authors:  Philip R Schauer; Bartolome Burguera; Sayeed Ikramuddin; Dan Cottam; William Gourash; Giselle Hamad; George M Eid; Samer Mattar; Ramesh Ramanathan; Emma Barinas-Mitchel; R Harsha Rao; Lewis Kuller; David Kelley
Journal:  Ann Surg       Date:  2003-10       Impact factor: 12.969

Review 10.  Glucagon-like peptide-1 synthetic analogs: new therapeutic agents for use in the treatment of diabetes mellitus.

Authors:  George G Holz; Oleg G Chepurny
Journal:  Curr Med Chem       Date:  2003-11       Impact factor: 4.530
View more
  9 in total

1.  Mid to distal small bowel resection with the preservation of the terminal ileum improves glucose homeostasis in diabetic rats by activating the hindgut-dependent mechanism.

Authors:  Jinyuan Duan; Jianping Zhou; Feng Ren; Cai Tan; Shaohua Wang; Lianwen Yuan
Journal:  J Gastrointest Surg       Date:  2014-04-01       Impact factor: 3.452

2.  Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.

Authors:  Alberto Patriti; Enrico Facchiano; Nino Gullà; Maria Cristina Aisa; Claudia Annetti
Journal:  Ann Surg       Date:  2007-01       Impact factor: 12.969

3.  Small Intestinal Bypass Induces a Persistent Weight-Loss Effect and Improves Glucose Tolerance in Obese Rats.

Authors:  Jiaqing Cao; Quan Ren; Cai Tan; Jinyuan Duan
Journal:  Obes Surg       Date:  2017-07       Impact factor: 4.129

4.  Duodenal-Jejunal Bypass Ameliorates Type 2 Diabetes Mellitus by Activating Insulin Signaling and Improving Glucose Utilization in the Brain.

Authors:  Na Li; Qing-Tao Yan; Qi Jing; Rui-Yan Pan; Huai-Jie Wang; Bin Jiang; Xian-Jun Li; Yi Wang; Jun-Hong Dong; Xue-Jian Wang; Mei-Jia Zhang; Qing-Guo Meng; Xiang-Zhen Li; Zhi-Jun Liu; Zhi-Qin Gao; Mei-Hua Qu
Journal:  Obes Surg       Date:  2020-01       Impact factor: 4.129

Review 5.  Rat models for bariatric surgery and surgery for type 2 diabetes mellitus.

Authors:  Sheetal Bharat Mistry; Juan J Omana; Subhash Kini
Journal:  Obes Surg       Date:  2009-03-06       Impact factor: 4.129

6.  A rodent model of metabolic surgery for study of type 2 diabetes and positron emission tomography scanning of beta cell mass.

Authors:  William B Inabnet; Luca Milone; Judith Korner; Evren Durak; Leaque Ahmed; Jill Pomrantz; Paul E Harris; Marc Bessler
Journal:  Surg Obes Relat Dis       Date:  2008-09-13       Impact factor: 4.734

7.  Effects of Bariatric Surgery on Serum Bile Acid Composition and Conjugation in a Diabetic Rat Model.

Authors:  Qunzheng Wu; Xiang Zhang; Mingwei Zhong; Haifeng Han; Shaozhuang Liu; Teng Liu; Meng Wei; Wei Guo; Haibin Xie; Sanyuan Hu; Guangyong Zhang
Journal:  Obes Surg       Date:  2016-10       Impact factor: 4.129

8.  Metabolic effects of an entero-omentectomy in mildly obese type 2 diabetes mellitus patients after three years.

Authors:  Fábio Quirilo Milleo; Antonio Carlos Ligocki Campos; Sérgio Santoro; Arnaldo Lacombe; Marco Aurélio Santo; Marcelo Ricardo Vicari; Viviane Nogaroto; Roberto Ferreira Artoni
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

9.  Changing Treatment Paradigm of Type 2 Diabetes.

Authors:  Kyung Yul Hur
Journal:  J Minim Invasive Surg       Date:  2020-09-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.